Market Size of DNA Sequencing Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 12.11 Billion |
Market Size (2029) | USD 28.79 Billion |
CAGR (2024 - 2029) | 18.91 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
DNA Sequencing Market Analysis
The DNA Sequencing Market size is estimated at USD 12.11 billion in 2024, and is expected to reach USD 28.79 billion by 2029, growing at a CAGR of 18.91% during the forecast period (2024-2029).
The COVID-19 pandemic had a positive impact on the market studied, as it increased the demand for DNA sequencing technology in the development of therapeutics and diagnostics for COVID-19 infection. For example, in November 2021, the Union Minister of State for Science and Technology India announced that the Department of Biotechnology (DBT) had completed one lakh genome and DNA sequencing for COVID-19 and that five COVID-19 biorepositories with 57,000 samples had been made available to academia and industry for R&D and product development. Hence, owing to the increasing DNA sequencing-based R&D activities in the development of diagnostic tools or effective therapeutics for COVID-19, the market is likely to continue its significant growth during the forecast period.
Certain factors driving market growth include advances in DNA sequencing technology, increased applications in clinical diagnosis and drug discovery, and increased R&D investments. DNA sequencing has applications in diagnostics, personalized medicine, biomarkers, forensics, reproductive health, and other areas. DNA sequencing technology holds great potential in clinical R&D of cancer diagnostics and therapeutics. Recently, next-generation sequencing (NGS) technology has demonstrated its capacity as a high-throughput and affordable approach to identify and characterize clinically actionable genetic variants across numerous genes at an exceptional speed in a single test. According to a research article published in the Journal of Pure and Applied Microbiology in June 2022, DNA sequencing methods have evolved throughout time to be employed in clinical diagnostic laboratories and research labs to produce high-quality results. It aids in the identification of new targets for therapy and diagnosis, broadening the horizon for patient care. Therefore, the increasing application of DNA sequencing in clinical diagnosis and drug discovery is expected to drive market growth over the forecast period.
The technological advancements in sequencing, from 2D sequencing in the 1970s to DNA sequencing, have come a long way. In recent years, platforms such as Illumina/Solexa, ABI/SOLiD, 454/Roche, and Helicos have provided unique prospects for high-throughput functional genomic research. Furthermore, the increased launch of technologically advanced DNA sequencing platforms is expected to propel market growth. For instance, in December 2021, Singular Genomics Systems, Inc. announced the commercial release of the G4, the benchtop sequencer. The NGS platform uses revolutionary high-performance chemistry and advanced engineering to provide precision, flexibility, speed, and power for a variety of applications, including oncology and immunology research.
Moreover, growing R&D activities are expected to raise demand for DNA sequencing due to its role in drug discovery and development. For instance, in July 2022, a genomics startup in California raised USD 600 million in funding to deliver a USD 100 whole human genome using its new high-throughput, low-cost sequencing platform.
Thus, all the above-mentioned factors are expected to propel the growth of the market. However, the interpretation of complex data and the lack of skilled professionals may restrain the market growth over the forecast period.
DNA Sequencing Industry Segmentation
As per the scope of the report, DNA sequencing is the procedure of determining or identifying the sequence of nucleotides within a DNA molecule. This information is useful for researchers in understanding the type of genetic information that is carried in the DNA, which may affect its function in the body. It can then, in turn, help to detect genetic changes that may be associated with causing certain health conditions. The DNA Sequencing Market is Segmented by Product Type (Instruments, Consumables, and Other Product Types), Sequencing Type (Sanger Sequencing, Next-generation Sequencing, and Other Sequencing Types), Application (Diagnostics, Personalized Medicine, and Other Applications), End User (Hospitals and Healthcare Organizations, Academics and Research Institutions, Pharmaceutical and Biotechnology Companies, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also studies the biopharmaceuticals market in 17 different countries across major regions across the world. The report offers the value (in USD million) for the above segments.
By Product Type | |
Instruments | |
Consumables (Kits and Reagents) | |
Other Product Types |
By Sequencing Type | |
Sanger Sequencing | |
Next-generation Sequencing | |
Other Sequencing Types |
By Application | |
Diagnostics | |
Personalized Medicine | |
Other Applications |
By End User | |
Hospitals and Healthcare Organizations | |
Academics and Research Institutions | |
Pharmaceutical and Biotechnology Companies | |
Other End Users |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
DNA Sequencing Market Size Summary
The DNA sequencing market is poised for significant expansion, driven by technological advancements and increased applications across various sectors such as clinical diagnostics, personalized medicine, and drug discovery. The market's growth trajectory is supported by the rising demand for next-generation sequencing (NGS) technologies, which offer high-throughput and cost-effective solutions for identifying genetic variants. The COVID-19 pandemic has further accelerated market growth by highlighting the critical role of DNA sequencing in developing diagnostics and therapeutics. The introduction of advanced sequencing platforms and the growing emphasis on research and development activities are expected to bolster the market's expansion over the forecast period.
North America leads the DNA sequencing market, fueled by substantial government and private sector investments in advanced technologies and supportive policies. The competitive landscape is characterized by the presence of major players such as Illumina, Thermo Fisher Scientific, and Roche, who are actively engaging in strategic initiatives like product launches and partnerships to enhance their market positions. Despite challenges such as data interpretation complexities and a shortage of skilled professionals, the market is anticipated to continue its robust growth, driven by ongoing innovations and the increasing adoption of sequencing technologies in various applications.
DNA Sequencing Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rise in Technological Advancements in DNA Sequencing
-
1.2.2 Increasing Application in Clinical Diagnosis and Drug Discovery
-
1.2.3 Growing Investments in R&D
-
-
1.3 Market Restraints
-
1.3.1 Interpretation of Complex Data and Lack of Skilled Professionals
-
1.3.2 Legal and Ethical Issues
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product Type
-
2.1.1 Instruments
-
2.1.2 Consumables (Kits and Reagents)
-
2.1.3 Other Product Types
-
-
2.2 By Sequencing Type
-
2.2.1 Sanger Sequencing
-
2.2.2 Next-generation Sequencing
-
2.2.3 Other Sequencing Types
-
-
2.3 By Application
-
2.3.1 Diagnostics
-
2.3.2 Personalized Medicine
-
2.3.3 Other Applications
-
-
2.4 By End User
-
2.4.1 Hospitals and Healthcare Organizations
-
2.4.2 Academics and Research Institutions
-
2.4.3 Pharmaceutical and Biotechnology Companies
-
2.4.4 Other End Users
-
-
2.5 Geography
-
2.5.1 North America
-
2.5.1.1 United States
-
2.5.1.2 Canada
-
2.5.1.3 Mexico
-
-
2.5.2 Europe
-
2.5.2.1 Germany
-
2.5.2.2 United Kingdom
-
2.5.2.3 France
-
2.5.2.4 Italy
-
2.5.2.5 Spain
-
2.5.2.6 Rest of Europe
-
-
2.5.3 Asia-Pacific
-
2.5.3.1 China
-
2.5.3.2 Japan
-
2.5.3.3 India
-
2.5.3.4 Australia
-
2.5.3.5 South Korea
-
2.5.3.6 Rest of Asia-Pacific
-
-
2.5.4 Middle-East and Africa
-
2.5.4.1 GCC
-
2.5.4.2 South Africa
-
2.5.4.3 Rest of Middle-East and Africa
-
-
2.5.5 South America
-
2.5.5.1 Brazil
-
2.5.5.2 Argentina
-
2.5.5.3 Rest of South America
-
-
-
DNA Sequencing Market Size FAQs
How big is the DNA Sequencing Market?
The DNA Sequencing Market size is expected to reach USD 12.11 billion in 2024 and grow at a CAGR of 18.91% to reach USD 28.79 billion by 2029.
What is the current DNA Sequencing Market size?
In 2024, the DNA Sequencing Market size is expected to reach USD 12.11 billion.